The rating assignments are based on several factors, including Inova’s robust financial performance, excellent liquidity position and leading market position.
Inova also faces numerous challenges, including elevated planned capital spending through fiscal year 2020.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Inova’s liquidity will remain strong and its operating cash flow margins will remain close to historical averages.
More articles on healthcare finance:
5 healthcare CFOs in the headlines
Florida governor signs law limiting balance billing: 5 things to know
S&P raises Kettering Health Network’s bond rating to ‘A+’
